Dr. concludes that all gel and bi-lumen implants: should be replaced at about the eighth post-operative year

[Guest guest]

Document #17

00/00/00 (I wish I had the date on this one!)

COHESIVENESS - LIQUID COMPONENT OF GEL

KNOWLEDGE OF GEL BLEED

MISCELLANEOUS

SILICA

Dow Corning materials identification list for final

devices. It lists all materials used in final devices

with a Dow Corning code number. The two manufacturing

sites, Michigan and Tennessee, use different

identification codes.

The list also gives material formulations, indicates

the need for a low-bleed outer shell liner, identifies

whether " responsive " gel or " firm " gel is used, and

notes the percentage of silica used in the

formulations.

CITE: KMM 447209 - 4477224

Dow Corning Trial Exhibit List Abstracts

Document #18

00/00/00

Post 10/92

COHESIVENESS - LIQUID COMPONENT OF GEL

KNOWLEDGE OF GEL BLEED

MISCELLANEOUS - COMPLICATIONS

RUPTURE

SHELL STRENGTH - THICKNESS

Dr. O. Gordon Presents a paper entitled " Rate

of Rupture of Silicone Prostheses:

Excerpt From A Study Of Over #3000 Personal Cases and

Twenty-Five Years Experience " at the Symposium on

Reoperative Aesthetic Surgery of the Face and Breast

in Naples. Florida. discusses results

obtained after 115 patients were followed after the

fall of 1990 after receiving breast implants. Of the

115 patients, 57% had rupture of one or both implants.

An additional 20% had moderate to severe bleed on one

or both sides. The patients had the implants from six

months to 25 years.

Dr. concludes that all gel and bi-lumen

implants:

should be replaced at about the eighth post-operative

year because it can be fairly well predicted that at

this stage the prostheses in most cases would still be

intact and much easier to replace. If a period of

time longer than twelve to fourteen years is allowed

to elapse, then the prostheses have a good chance of

being ruptured and the exchange would be much more

difficult.

CITE: PSC Medical Articles CD, J 2698 - Exhibit 2 to

Deposition, Exhibit 25 to McKennon

Deposition.

WITNESS: . DISPOSITION: Not admitted in Toole

(II) v. Baxter Healthcare

Dow Corning Trial Exhibit List